Journal article
Cancers attributable to human papillomavirus infection
AE Grulich, F Jin, EL Conway, AN Stein, J Hocking
Sexual Health | Published : 2010
DOI: 10.1071/SH10020
Abstract
Although the human papillomavirus (HPV) vaccine was introduced primarily as a cervical cancer prevention vaccine, HPV has a causal role in several types of cancer. This article reviews the epidemiological evidence for the role of HPV in human cancer, and describes Australian trends in these cancers. HPV is a necessary cause of cervical cancer. The currently vaccine-preventable subtypes of HPV 16 and 18 are responsible for ∼70% of cervical cancer. The introduction of an organised Pap smear program in Australia led to a steep decline in incidence over the past decades. HPV can be detected in ∼40% and 70% of vulval and vaginal cancers respectively. Rates of these cancers have been stable over t..
View full abstractGrants
Funding Acknowledgements
Andrew Grulich is on the advisory board for the Gardasil quadrivalent human papillomavirus vaccine, and has received research funding from CSL, the Australian distributor of the Gardasil vaccine. Alicia Stein and Lynne Conway are employees of CSL.